Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma

表观基因组状态转变是小鼠肺腺癌肿瘤进展的特征

阅读:1
作者:Lindsay M LaFave ,Vinay K Kartha ,Sai Ma ,Kevin Meli ,Isabella Del Priore ,Caleb Lareau ,Santiago Naranjo ,Peter M K Westcott ,Fabiana M Duarte ,Venkat Sankar ,Zachary Chiang ,Alison Brack ,Travis Law ,Haley Hauck ,Annalisa Okimoto ,Aviv Regev ,Jason D Buenrostro ,Tyler Jacks

Abstract

Regulatory networks that maintain functional, differentiated cell states are often dysregulated in tumor development. Here, we use single-cell epigenomics to profile chromatin state transitions in a mouse model of lung adenocarcinoma (LUAD). We identify an epigenomic continuum representing loss of cellular identity and progression toward a metastatic state. We define co-accessible regulatory programs and infer key activating and repressive chromatin regulators of these cell states. Among these co-accessibility programs, we identify a pre-metastatic transition, characterized by activation of RUNX transcription factors, which mediates extracellular matrix remodeling to promote metastasis and is predictive of survival across human LUAD patients. Together, these results demonstrate the power of single-cell epigenomics to identify regulatory programs to uncover mechanisms and key biomarkers of tumor progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。